4//SEC Filing
MEDecision, Inc. 4
Accession 0000930413-08-004233
CIK 0001367705operating
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 8:55 PM ET
Size
23.8 KB
Accession
0000930413-08-004233
Insider Transaction Report
Form 4
MEDecision, Inc.MEDE
KROIN DAVID
10% Owner
Transactions
- Sale
Common Stock
2008-07-07$6.61/sh−9,321$61,626→ 655,679 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-08$6.58/sh−11,129$73,261→ 1,105,297 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.58/sh−51,888$341,574→ 603,791 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-07$6.61/sh−15,871$104,931→ 1,116,426 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.58/sh−77,223$508,351→ 1,028,074 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.57/sh−31,500$206,861→ 996,574 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.57/sh−9,164$60,207→ 585,291 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-01$6.65/sh−161,755$1,075,671→ 665,000 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Purchase
Common Stock
2008-07-01$6.65/sh+161,755$1,075,671→ 1,132,297 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.57/sh−9,336$61,338→ 594,455 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
JAY JEFFREY R
10% Owner
Transactions
- Sale
Common Stock
2008-07-08$6.58/sh−11,129$73,261→ 1,105,297 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-07$6.61/sh−15,871$104,931→ 1,116,426 total(indirect: By Biomedical Value Fund, L.P.) - Purchase
Common Stock
2008-07-01$6.65/sh+161,755$1,075,671→ 1,132,297 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.58/sh−77,223$508,351→ 1,028,074 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.57/sh−9,164$60,207→ 585,291 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-08$6.57/sh−9,336$61,338→ 594,455 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-07$6.61/sh−9,321$61,626→ 655,679 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-08$6.57/sh−31,500$206,861→ 996,574 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.58/sh−51,888$341,574→ 603,791 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-01$6.65/sh−161,755$1,075,671→ 665,000 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
GREAT POINT PARTNERS LLC
10% Owner
Transactions
- Sale
Common Stock
2008-07-08$6.58/sh−51,888$341,574→ 603,791 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Purchase
Common Stock
2008-07-01$6.65/sh+161,755$1,075,671→ 1,132,297 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.57/sh−9,164$60,207→ 585,291 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-07$6.61/sh−15,871$104,931→ 1,116,426 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-08$6.57/sh−31,500$206,861→ 996,574 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-07$6.61/sh−9,321$61,626→ 655,679 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-08$6.57/sh−9,336$61,338→ 594,455 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-08$6.58/sh−11,129$73,261→ 1,105,297 total(indirect: By Biomedical Value Fund, L.P.) - Sale
Common Stock
2008-07-01$6.65/sh−161,755$1,075,671→ 665,000 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Sale
Common Stock
2008-07-08$6.58/sh−77,223$508,351→ 1,028,074 total(indirect: By Biomedical Value Fund, L.P.)
Footnotes (3)
- [F1]On July 1, 2008, Biomedical Offshore Value Fund, Ltd. ("BOVF") sold 161,755 shares of Common Stock of MEDecision, Inc. to Biomedical Value Fund, L.P. ("BMVF") at a purchase price of $6.65 per share. The purchase price was the closing market price for the shares on June 30, 2008.
- [F2]Great Point Partners, LLC ("Great Point") is the investment manager of BMVF and by virtue of such status may be deemed to be the beneficial owner of the shares held by BMVF. Each of Dr. Jeffrey R. Jay, M.D. ("Dr. Jay"), as senior managing member of Great Point, and Mr. David Kroin ("Mr. Kroin"), as special managing member of Great Point, has voting and investment power with respect to the shares held by BMVF and may be deemed to be the beneficial owner of the shares held by BMVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares held by BMVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities.
- [F3]Great Point is the investment manager of BOVF and by virtue of such status may be deemed to be the beneficial owner of the shares held by BOVF. Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the shares held by BOVF and may be deemed to be the beneficial owner of the shares held by BOVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares held by BOVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities.
Documents
Issuer
MEDecision, Inc.
CIK 0001367705
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0001367705
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 8:55 PM ET
- Size
- 23.8 KB